17␤-Estradiol (E 2 ) induces c-fos protooncogene expression in MCF-7 human breast cancer cells, and previous studies in HeLa cells identified an imperfect palindromic estrogen-responsive element (Ϫ1212 to Ϫ1200) that was required for trans-activation. In contrast, the estrogen-responsive element was not required for E 2 responsiveness in MCF-7 cells, and using a series of constructs containing wildtype (pF1) and mutant 5Ј-flanking sequences (Ϫ1220 to Ϫ1155) from the c-fos protooncogene promoter in transient transfection assays, it was shown that a GC-rich motif (5Ј-GGGGCGTGG) containing an imperfect Sp1-binding site was required for hormone-induced activity. This sequence also bound Sp1 protein in gel mobility shift assays, and coincubation with the estrogen receptor (ER) enhanced Sp1-DNA binding. E 2 and 4Ј-hydroxytamoxifen, but not ICI 164,384, induced reporter gene activity in cells transiently transfected with pF1. E 2 induced reporter gene activity in MDA-MB-231 breast cancer cells transiently cotransfected with pF1 and wild-type ER or variant ER in which the DNA-binding domain was deleted (HE11); plasmids expressing N-terminal or C-terminal domains of the ER containing activator function-1 or -2, respectively, were inactive in these assays. In contrast, only wild-type ER mediated 4Ј-hydroxytamoxifeninduced activity. Induction of c-fos protooncogene expression by E 2 in MCF-7 cells is dependent on the formation of a transcriptionally active ER/Sp1 complex that binds to a GC-rich enhancer element.
T HE PROTOONCOGENE c-fos plays an important role in
the regulation of normal cell growth and cellular transformation processes (1) (2) (3) (4) . c-fos is a prototypical immediateearly gene that is rapidly induced in cells/tissues in response to diverse extracellular stimuli, including various mitogens and the steroid hormone 17␤-estradiol (E 2 ) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) .The protooncogene c-fos encodes a nuclear protein that interacts with c-jun to form the heterodimeric activating protein-1 (AP-1) transcription factor complex (1) (2) (3) (4) . AP-1 sites have been widely identified in mammalian gene promoters, and interaction of Fos-Jun heterodimers with AP-1 sites and other proteins can result in increased or decreased gene expression that is dependent on cellular and promoter context and interacting proteins. For example, overexpression of Fos and Jun inhibits estrogen receptor (ER)-mediated trans-activation in several different cell lines (21) (22) (23) . In contrast, some promoter-reporter constructs containing AP-1 sites are activated by the ER, and induced gene expression is dependent not only on promoter and cell context, but also on specific ER domains and ligand structure (24 -26) . For example, tamoxifen induces AP-1-dependent activity in endometrial, but not breast cancer, cell lines, and the induction response requires the expression of activator function-1 (AF-1), AF-2, and the DNA-binding domain of the ER (26) . E 2 -induced trans-activation was less cell specific than reported for tamoxifen, and both wild-type ER and a truncated form of ER lacking the DNA-binding domain were functional (26) . Thus, interplay among Jun, Fos, the ER, and various ER ligands can modulate gene expression from promoter sequences that bind ER or AP-1.
c-fos protooncogene expression is induced by E 2 alone or in combination with insulin and other mitogenic polypeptides (15) (16) (17) (18) (19) (20) . A 2.25-kilobase human c-fos gene promoter sequence linked to a bacterial chloramphenicol acetyltransferase (CAT) reporter gene was E 2 responsive in transient transfection assays in HeLa cells, and hormone inducibility was localized to a 240-bp region (Ϫ1300 to Ϫ1060) (27) . Sequence analysis identified an imperfect palindromic estrogen-reponsive element (ERE) within this region (5Ј-CGGCAGCGTGACC-3Ј) that bound the ER in gel mobility shift assays. However, insertion of a single copy of this sequence in the promoter-reporter construct did not result in the induction of reporter gene activity by E 2 in HeLa cells, and hormone-induced trans-activation was observed only with a promoter containing multiple (n ϭ 3) EREs (27) .
Initial studies in this laboratory showed that E 2 induced CAT activity in MCF-7 cells transiently transfected with a construct containing 1.4 kilobases from the c-fos gene promoter linked to a CAT reporter gene. Induction was not observed using a construct containing the imperfect palindromic ERE (Ϫ1212 to Ϫ1200), and this paralleled results obtained in HeLa cells (27) . A recent study in this laboratory showed that ER and Sp1 physically interact, and E 2 -induced trans-activation was observed using constructs containing only a GC-rich oligonucleotide insert (28) . The results were in contrast to studies with constructs containing cathepsin D gene promoter inserts in which E 2 responsiveness was associated with the formation of an ER/Sp1 complex that bound to an Sp1(N) 23 ERE half-site motif (29, 30) . A GC-rich motif was identified downstream from the imperfect palindromic ERE in the fos gene promoter at Ϫ1168 to Ϫ1161, and the E 2 responsiveness of the Ϫ1220 to Ϫ1155 region was investigated using promoter-TATA-CAT constructs in transient transfection assays in MCF-7 cells. E 2 induced transactivation of fos gene promoter-reporter constructs that do not contain the imperfect palindromic ERE (Ϫ1212 to Ϫ1200), and the enhancer element required for induction by E 2 was the GC-rich sequence (5Ј-GGGGCGTGG-3Ј) that bound the nuclear protein Sp1 and formed a transcriptionally active ER/Sp1 protein complex. Hormone-induced trans-activation did not require the ER DNA-binding domain, suggesting that ER acts directly on the Sp1 protein and increases transcriptional activity through enhanced binding of Sp1 to its cognate GC-rich site.
Materials and Methods

Chemicals, cell lines, and oligonucleotides
MCF-7 and MDA-MB-231 cell lines were obtained from the American Type Culture Collection (Rockville, MD). Cells were routinely maintained in MEM with phenol red and supplemented with 10% FBS plus 10 ml antibiotic-antimycotic solution (Sigma Chemical Co., St. Louis, MO) in an air-carbon dioxide (95:5) atmosphere at 37 C. For transient transfection studies, cells were grown for 1 day in DMEM-Ham's F-12 medium without phenol red and 5% FBS treated with dextran-coated charcoal. The wild-type human ER (hER) expression plasmid was provided by Ming Jer Tsai (Baylor College of Medicine, Houston, TX). Recombinant ER was obtained from PanVera Corp. (Madison, WI). The ER deletion mutants HE11, HE15, and HE19 were provided by Pierre Chambon (CNRS, Strasbourg, France). Dimethylsulfoxide (DMSO) was used as solvent for E 2 and the antiestrogens. 4Ј-Hydroxytamoxifen was purchased from Sigma Chemical Co.; ICI 164,384 was provided by Alan Wakeling (Zeneca Pharmaceuticals, Macclesfield, UK). All other chemicals and biochemicals were the highest quality available from commercial sources.
Oligonucleotides derived from the c-fos protooncogene promoter and a consensus Sp1 oligonucleotide were synthesized by the Gene Technologies Laboratory, Texas A&M University (College Station, TX). The structures of these oligonucleotides are summarized below, and the putative GC-rich Sp1 and ERE sites are underlined. Mutations incorporated in the mutant oligonucleotides are denoted by an asterisk: fos1 (Ϫ1220/Ϫ1155), sense strand, 5Ј-AGC TTG GCT GAG CCG GCA GCG TGA CCC CGG CTG TCC TAC GCA GCA GGG CAG GAG ATT GGG GGG CGT GGC ACG-3Ј; fos2 (Ϫ1220/Ϫ1171), sense strand, 5Ј-AGC TTG GCT GAG CCG GCA GCG TGA CCC CGG CTG TCC TAC GCA GCA GGG CAG GAG AG-3Ј; fos3 (Ϫ1222/Ϫ1197), sense strand, 5Ј-AGC TTG GCT GAG CCG GCA GCG TGA CCC CGG CG-3Ј; fos4 (Ϫ1175/ Ϫ1153), sense strand, 5Ј-AGC TTG GAG ATT GGG GGG CGT GGC ACA CG-3Ј; fos1-m1 (Ϫ1220/Ϫ1155), sense strand, 5Ј-AGC TTG GCT GAG CCG GCA GCG TGA CCC CGG CTG TCC TAC GCA GCA GGG CAG GAG ATT GGG T*T*A* A*GT GGC ACG-3Ј (mutation of Sp1 site); fos1-m3 (Ϫ1220/Ϫ1155), sense strand, 5Ј-AGC TTG GCT GAG CCA* T*A*T* GCG TA*G* A*C*C CGG CTG TCC TAC GCA GCA T*A*G* A*T*G GAG ATT GGG GGG CGT GGC ACG Ϫ 3Ј (mutation of three ERE half-sites); and Sp1 (consensus), sense strand, 5Ј-AGC TTA TTC GAT CGG GGC GGG GCG AGC G-3Ј.
Cloning
The inserts encoding the wild-type hER, HE11, HE15, and HE19 ER deletion variants were removed by digesting the appropriate plasmids with EcoRI. The inserts were then religated into pcDNA3-neo (Invitrogen, Carlsbad, CA) that had been linearized with EcoRI and treated with calf intestinal alkaline phosphatase. The ligation products were transformed into DH5a cells, and clones were verified by sequencing. The in vitro translation efficiency for these plasmids was determined by 35 S labeling experiments followed by separation of radiolabeled wild-type and variant ER by electrophoresis. The levels of wild-type and variant ER protein expressed were comparable based on radiolabeled band intensities (corrected for methionine content in the individual proteins). The pBLTATA-CAT plasmid was made by digesting the pBLCAT2 vector with BamHI and XhoI to remove the thymidine kinase promoter; the double stranded E1B oligonucleotide (28) containing complementary 5Ј-overhangs was then inserted into the corresponding sites. The fos1, fos2, fos3, fos4, and fos1.m3 oligonucleotides were cloned into the pBLTATA-CAT vector at the HindIII and BamHI sites to give the pF1, pF2, pF3, pF4, and pF1.m3 constructs, respectively, as previously described (28) .
Transient transfection assay
MCF-7 and MDA-MB-231 cells were transfected using the calcium phosphate method with 10 g c-fos gene promoter-derived constructs and 1 g (MCF-7 cells) or 5 g (MDA-MB-231 cells) wild-type or variant ER expression plasmids; this was due to overexpression of these constructs. Previous studies have also shown the requirement for cotransfection of hER expression plasmid using other E 2 -responsive constructs (27) (28) (29) (30) . E 2 responsiveness was observed only after cotransfection with ER expression plasmids. pcDNA3-neo (Invitrogen) was used as an empty vector (control) and was also added in some experiments to maintain uniform levels of added DNA. Transfection efficiency was high, and no additional shock was required. After 18 h, the medium was changed, and the cells were treated with DMSO (0.2% total volume), E 2 , 4Ј-hydroxy-tamoxifen, ICI 164,384, or their combinations in DMSO for 44 h. Cells were then washed with PBS and scraped from the plates. Cell lysates were prepared in 0.15 ml 0.25 m Tris-HCl (pH 7.5) by three freeze-thaw-sonication cycles (3 min each). Protein concentrations were determined using BSA as a standard, and analysis for CAT activity in cell lysates used a constant amount of protein from each treatment group. Lysates were incubated at 56 C for 7 min to remove endogenous deacetylase activity. CAT activity was determined by incubating aliquots of the cell lysates with 0.
mCi d-threo-[dichloroacetyl-1-
14 C]chloramphenicol and 4 mm acetyl coenzyme A. Acetylation was allowed to proceed to less than 20 -25% completion (linear range), and acetylated metabolites were analyzed by TLC. After TLC, acetylated products were visualized and quantitated using a Betagen Betascope 603 blot analyzer (Intelligenetics, Mountain View, CA). CAT activity was calculated as a fraction of that observed in cells treated with DMSO alone (arbitrarily set at 100), and results are expressed as the mean Ϯ sd. The experiments were carried out at least in triplicate.
Electrophoretic mobility shift assays
Pure Sp1 protein was purchased from Promega (Madison, WI). Expression plasmids for wild-type ER, HE11, HE15, and HE19 were used to in vitro transcribe and translate the corresponding proteins in a rabbit reticulocyte lysate kit (Promega). Gel electromobility shift assays were performed using Sp1 protein and in vitro translated proteins in 1 ϫ binding buffer (20 mm HEPES, 5% glycerol, 100 mm potassium chloride, 5 mm magnesium chloride, 0.5 mm dithiothreitol, and 1 mm EDTA in a final volume of 25 l). E 2 was added to the reaction at a final concentration of 20 nm and then incubated on ice for 15 min. Sp1 and 32 P-labeled oligonucleotides were then added to the reaction mixtures in the presence of 1 g poly(dI-dC) and incubated for 15 min at 25 C. In competition experiments, different amounts of unlabeled oligonucleotides were also included in the incubation mixtures. Aliquots of these mixtures were loaded onto a 4% polyacrylamide gel (acrylamide/bisacrylamide ratio, 30:0.8) and run at 110 V in 0.09 m Tris-0.09 m borate-2 mm EDTA (pH 8.3).
32 P-Labeled DNA and DNA-protein bands were visualized by autoradiography and quantitated by densitometry using the Molecular Dynamics Zero-D software package (Molecular Dynamics, Sunnyvale, CA) and a Sharp JX-330 scanner (Mahwah, NJ).
Results
Previous studies demonstrated that an imperfect palindromic ERE (Ϫ1212 to Ϫ1200), which bound ER protein in gel mobility shift assays, was contained within a 240-bp (Ϫ1300 to Ϫ1060) E 2 -responsive region of the c-fos protooncogene promoter (27) . One copy of the c-fos ERE cloned into pBL-CAT2 upstream from a thymidine kinase promoter did not confer E 2 responsiveness on the resulting construct; however, a sequence containing three copies of the ERE was E 2 responsive in transient transfection studies in HeLa cells (27) . A series of TATA-CAT plasmids containing Ϫ1220 to Ϫ1155 (pF1), Ϫ1220 to Ϫ1171 (pF2), Ϫ1222 to Ϫ1197 (pF3), and Ϫ1175 to Ϫ1153 (pF4) sequences from the c-fos gene promoter was transiently transfected into MCF-7 cells and treated with 10 nm E 2 , and CAT activity was determined. In cells transiently transfected with pF1, there was a 4-fold induction of CAT activity by E 2 ; in contrast, the truncated constructs pF2 and pF3 and the plasmid containing only the TATA promoter exhibited minimal activity and hormone responsiveness (Fig. 1A) . Results of transient transfection studies using pF1-m2 (containing the Ϫ1220/Ϫ1155 insert mutated in the perfect ERE half-site) also showed that this construct was E 2 responsive (data not shown). These results suggested that the Ϫ1171 to Ϫ1153 region of the promoter containing a GC-rich site (GGGGCGTGG) was required for E 2 responsiveness, and in MCF-7 cells transiently transfected with pF4, E 2 caused a 3.2-fold increase in CAT activity (Fig. 1B) ; similar results were obtained using pF1 (5.5-fold induction) and pF1-m3 (4.7-fold induction) in which the three ERE half-sites were mutated. The results (Fig. 1) indicate that E 2 responsiveness of pF1 is associated with the GC-rich region of the c-fos gene promoter (Ϫ1220 to Ϫ1155).
The fos1 oligonucleotide contains a GC-rich site and three ERE half-sites; therefore, there are at least three possible Sp1(N) x ERE (half-site) motifs within this region of the promoter. Previous studies have demonstrated that functional Sp1(N) x ERE (half-site) elements within the Hsp27 and cathepsin D gene promoters bind nuclear extracts from MCF-7 cells to form ER/Sp1-DNA complexes (29 -31) . In contrast, incubation of [ 32 P]fos1 with nuclear extracts did not give a retarded band associated with the formation of this complex (data not shown). Therefore, the interaction of Sp1 protein FIG. 1. E 2 responsiveness of constructs derived from the c-fos gene promoter. A, Effect of E 2 on CAT activity in MCF-7 cells transfected with pF1, pF2, or pF3. MCF-7 cells were transiently cotransfected with hER and pF1 (lanes 1 and 2), pF2 (lanes 3 and 4), pF3 (lanes 5 and 6), or TATA-CAT vector alone (lanes 7 and 8). The transient transfection and CAT assays were performed as described in Materials and Methods. Cells were treated with DMSO (C; lanes 1, 3, 5, and 7) or 10 nM E 2 (E; lanes 2, 4, 6, and 8). The relative intensities of acetylated products in lanes 2, 4, and 6 compared with those of control (C) bands (lanes 1, 3, and 5; arbitrarily set at 100) were 403 Ϯ 142, 166 Ϯ 78, and 273 Ϯ 60, respectively. Significant induction (P Ͻ 0.01) was only observed for pF1; basal activities were significantly lower for pF2, pF3, and TATA-CAT, and no significant induction by E 2 was observed (results are the mean Ϯ SD for three separate determinations). B, Effect of E 2 on CAT activity in MCF-7 cells transfected with pF1, pF4, or pF1-m3. MCF-7 cells were transiently cotransfected with hER and pF1 (lanes 1 and 2), pF1-m3 (lanes 3 and 4), pF4 (lanes 5 and 6), or TATA-CAT vector alone (lanes 7 and 8) . The transient transfection and CAT assays were performed as described in Materials and Methods. Cells were treated with DMSO (C; lanes 1, 3, 5, and 7) or 10 nM E 2 (E; lanes 2, 4, 6, and 8). The relative intensities of acetylated products in lanes 2, 4, and 6 compared with those of control (C) bands (lanes 1, 3, and 5; arbitrarily set at 100) were 552 Ϯ 30, 471 Ϯ 36, and 317 Ϯ 17, respectively. Relative intensities in lanes 2, 4, and 6 were significantly higher (P Ͻ 0.001) than those in control cells (lanes 1, 3, and 5 ; results are the mean Ϯ SD for three separate determinations). No significant induction by E 2 was observed for the TATA-CAT vector (lane 8). In a separate experiment using pF1-m1, no significant induction by E 2 was observed (data not shown).
with the GC-rich site in the c-fos promoter was investigated in both direct and indirect binding studies (Fig. 2, A and B) . Sp1 protein bound to [ 32 P]Sp1 (containing a consensus Sp1 sequence) to form a retarded band (Fig. 2A, lane 2 2B, lane 1) was competitively inhibited after coincubation with a 400-fold excess of unlabeled Sp1 (lane 2) or fos1-m3 (lane 3) oligonucleotides, whereas competition with the fos1-m1 oligonucleotide, which is mutated in the GC-rich site, did not decrease formation of the retarded band (lane 4). These results demonstrate that Sp1 protein interacts with the same GC-rich sequence (Ϫ1175 to Ϫ1153) required for E 2 responsiveness in transient transfection assays (Fig. 1) . [ 32 P]fos1-m3 bound Sp1 to form a specifically bound retarded band (Fig. 3B, lanes 2-4) , and coincubation of Sp1 (3 ng) (lane 6) with different concentrations of recombinant ER (lanes 7-9) resulted in a concentration-dependent increase in the intensity of the retarded band. Previous studies using a consensus [ 32 32 P]fos1-m3 and analyzed by gel mobility shift assay as described in Materials and Methods. Total protein per incubation was kept constant by the addition of BSA. The relative intensity values in lanes 3-5 relative to that in lane 2 (arbitrarily set at 100) were 187 Ϯ 17, 283 Ϯ 51, and 43 Ϯ 13, respectively. The relative intensities in lanes 7-10 relative to that in lane 6 (arbitrarily set at 100) were 153 Ϯ 8, 248 Ϯ 34, 321 Ϯ 3, and 29 Ϯ 0.5, respectively. Band intensities in lanes 3 and 4 (relative to that in lane 2) and lanes 7-9 (relative to that in lane 6) were significantly (P Ͻ 0.05) increased. Results are the mean Ϯ SD for three separate determinations. B, Effect of wild-type and variant ER. In vitro translated proteins were obtained, and gel shift analysis was performed as described in Materials and Methods using 5 ng Sp1 protein and 1 l of the reticulocyte lysate preparation. The intensities of lanes 4, 6, 8, 10, and 12 relative to that of the control band (lane 2; 100 Ϯ 13) were 214 Ϯ 11, 262 Ϯ 41, 119 Ϯ 6, 110 Ϯ 13, and 95 Ϯ 6. The intensities in lanes 4 and 6 were significantly higher (P Ͻ 0.001) than that in lane 2 (results are the mean Ϯ SD for three separate determinations).
The effects of both E 2 and antiestrogens on trans-activation were also investigated in MCF-7 or MDA-MB-231 cells cotransfected with pF1 or pF1-m3 constructs and full-length or variant ER expression plasmids (Figs. 4-7) . The pure antiestrogen ICI 164,384 did not induce CAT activity in MCF-7 cells transiently transfected with pF1 (Fig. 4A, lane 3) ; however, in cells cotreated with E 2 plus ICI 164,384, the hormone-induced response was decreased by 79% (lane 4). In contrast, 1 m 4Ј-hydroxytamoxifen did not exhibit antiestrogenic activity (lane 6), but was active as an ER agonist and induced CAT activity (4.2-fold; lane 5). Similar results were obtained in MCF-7 cells transiently transfected with pF1-m3, which contains the Ϫ1220 to Ϫ1155 region of the fos promoter in which the GC-rich site is intact and all three ERE sites are mutated (Fig.  4B ). E 2 and 4Ј-hydroxytamoxifen induced CAT activity (2.6-and 2.1-fold, respectively; lanes 2 and 5), whereas ICI 164,384
was not an ER agonist (lane 3). In cells cotreated with both antiestrogens (lanes 4 and 6), only ICI 164,384 inhibited E 2 -induced CAT activity. The results summarized in Figs. 5 and 6 show that CAT activity is induced by E 2 in MCF-7 and MDA-MB-231 cell cotransfected with pF1 or pF1-m3 and hER or HE11 expression plasmids. Induction was not observed in cells cotransfected with HE15 or HE19 expression plasmids or with a control vector (pcDNA3-neo) that does not contain an E 2 -responsive promoter insert. 4Ј-Hydroxytamoxifen also induced CAT activity in MDA-MB-231 cells transiently cotransfected with pF1 and full-length ER expression plasmid (Fig. 7) ; in contrast, CAT activity was not induced in cells cotransfected with variant HE11, HE15, or HE19 ER expression plasmids. These results demonstrate that E 2 activates HE11/Sp1 or ER/ Sp1 complexes (Figs. 5 and 6 ), whereas 4Ј-hydroxytamoxifen activates only the ER/Sp1 complex (Fig. 7) . 
Discussion
The c-fos protooncogene is induced by E 2 , mitogenic peptides, and insulin in MCF-7 human breast cancer cells (15) (16) (17) (18) (19) (20) . Molecular analysis of the c-fos protooncogene promoter identified an imperfect palindromic ERE (Ϫ1212 to Ϫ1200) that bound the ER in a gel mobility shift assay but in HeLa cells did not confer E 2 responsiveness on a promoter-reporter construct containing a single copy of the ERE sequence (27) . Inducibility was only observed using plasmids containing three copies of the fos-ERE, and this was consistent with the reported synergistic ER-mediated activation of constructs containing multiple tandem responsive elements (32) . Recent studies have shown that ER/Sp1 complexes that bind directly to GC-rich Sp1-binding sites mediate hormoneinduced trans-activation (28) . Moreover, functional interactions between ER and Sp1 proteins are accompanied by physical interactions between the two transcription factors (28) .
An Sp1-like motif was identified (Ϫ1168 to Ϫ1161) 3Ј to the palindromic ERE in the fos gene promoter, and the results of transient transfection studies using a construct (pF1) that contained the Ϫ1220 to Ϫ1155 region of the fos gene promoter showed that E 2 induced CAT activity (Fig. 1) . In contrast, Weisz and Rosales (27) previously reported that a construct containing the imperfect palindromic ERE (Ϫ1212 to Ϫ1200) was not E 2 responsive. This confirmed that downstream sequences (Ϫ1200 to Ϫ1155) were required for E 2 responsiveness, and the identities of these elements were further investigated using a series of wild-type (pF1-pF4) and mutant (pF1⅐m3) constructs containing fos gene promoter sequences.
The fos gene promoter sequence inserted in pF1 (Ϫ1220 to Ϫ1155) contains two ERE half-sites that include the imperfect palindromic ERE, a third ERE half-site, and a GC-rich sequence (Ϫ1168 to Ϫ1161) that is a putative binding site for the nuclear Sp1 protein. Previous studies have shown that Sp1(N) x ERE half-site motifs within the cathepsin D, heat shock protein-27, c-myc, creatine kinase B, and retinoic acid receptor-␣ gene promoters bind ER/Sp1 complexes and confer E 2 inducibility on their corresponding promoter-reporter constructs (30, 31, (33) (34) (35) . The Ϫ1120 to Ϫ1155 region of the fos gene promoter insert in pF1 contains three potential Sp1(N) x ERE half-site motifs; however, incubation of [ 32 P]fos1 with nuclear extracts from MCF-7 cells did not give an ER/ Sp1-retarded band (data not shown). Therefore, the functionality of fos gene promoter sequences was further investigated. The results illustrated in Fig. 1 show that pF1, which contains both the GC-rich and ERE sequences, was E 2 responsive, and deletion of the GC-rich region (pF2 and pF3) within the promoter resulted in the loss of hormone-induced trans-activation. These data showed that the GC-rich site was necessary for E 2 responsiveness, but did not exclude a role for a functional Sp1(N) x ERE half-site. However, transient transfection studies using a plasmid containing mutations in the three ERE half-sites (pF1-m3) or a construct containing the GC-rich site alone (pF4; Ϫ1175 to Ϫ1153) demonstrated that the GC elements were both necessary and sufficient for E 2 -induced trans-activation.
The E 2 -responsive Ϫ1175 to Ϫ1153 region of the c-fos protooncogene promoter contains a potential nonconsensus Sp1 element (5Ј-GGGGCGTGG-3Ј), and the result show that, like [ 32 P]Sp1, both wild-type [ 32 P]fos1, and mutant [ 32 P]fos1-m3 oligonucleotides bind Sp1 protein to form retarded bands that are competitively decreased only after coincubation with unlabeled oligonucleotides containing intact Sp1-binding sites. Miltenberger and co-workers (36) have previously identified a GGGGCGTGG sequence in the multidrug-resistant gene promoter that also binds Sp1 protein and plays an important role in basal expression of this gene. A comparison of the results obtained with pF1, pF2, pF3, and pF4 indicates that basal CAT activity was markedly decreased using plasmids that did not contain the GC-rich site (i.e. pF2 and pF3), suggesting that Sp1 binding may also be required for optimal basal expression of c-fos.
Recent studies in this laboratory have shown that GC-rich sites that bind the Sp1 transcription factor mediated E 2 -induced trans-activation (28) . For example, E 2 induced CAT activity in transient transfection studies in MCF-7 cells (cotransfected with hER) using a plasmid containing a consensus Sp1 oligonucleotide insert. Moreover, in gel mobility shift assays using the same consensus [ 32 P]Sp1 oligonucleotide, coincubation with ER increased the overall rate and levels of Sp1-[ 32 P]Sp1 complex formation, and in parallel studies using wild-type and ER variant (HE11, HE15, and HE19) expression plasmids, only hER and HE11 enhanced Sp1-[ 32 P]Sp1 binding (28) . The results illustrated in Fig. 3 using the [
32 P]fos1-m3 oligonucleotide demonstrate that wild-type hER and HE11 (DNA-binding domain deficient) also enhanced (Ͼ2-fold) formation of the Sp1-[ 32 P]fos1-m3 complex, whereas HE15 and HE19, which express AF1 and AF2, respectively, did not enhance retarded band formation. Although ER and Sp1 physically interact (28), a ternary ERSp1-DNA complex was not observed in this study or a previous report (28) . The observation that a protein (i.e. ER homodimer) enhanced the binding of another protein (i.e. Sp1) to its cognate sequence without forming a ternary complex in a gel mobility shift assay has been observed in other studies showing that human T cell leukemia virus type-1 Tax, sterol regulatory element-binding protein, and cyclin D1 enhanced bZIP, Sp1 and ER binding to their respective DNA enhancer sequences (37) (38) (39) .
c-fos proto-oncogene expression is induced by both E 2 and 4Ј-hydroxytamoxifen in MCF-7 cells, whereas ICI 164,384 exhibits ER antagonist activity (19, 40) . The activities of these ligands as ER agonists/antagonists were comparable in MCF-7 cells cotransfected with hER and pF1 or pF1-m3, thus confirming that ER/Sp1 binding to the GC-rich motif (Ϫ1168 to Ϫ1161) plays an important role in E 2 -mediated transactivation of this gene. Transcriptionally active ER-protein complexes have also been observed with the AP-1 Fos-Jun complex, and the effects of ER-AP-1 trans-activation through AP-1 sites are dependent on the cell and promoter context and on the ligand (i.e. estrogens vs. antiestrogens) (24 -26) . For example, ER binds to Jun (but not Fos), E 2 activates AP-1-dependent activity in transient transfection assays, and trans-activation is observed with both wild-type ER and HE11 in both MCF-7 and Ishikawa (endometrial) cell lines. The results summarized in Figs. 5 and 6 demonstrate that E 2 -mediated induction of CAT activity in MCF-7 or MDA-MBA-231 breast cancer cells transfected with pF1 or pF1-m3 is also dependent on cotransfection with wild-type hER or HE11. In contrast, tamoxifen-induced CAT activity in MDA-MB-231 cells transfected with pF1 was observed only in cells cotransfected with wild-type hER. Thus, important liganddependent (E 2 vs. tamoxifen) differences were observed for ER/Sp1-mediated trans-activation. These data also illustrate important ligand-dependent differences in trans-activation by ER/Sp1 and ER-AP-1 complexes, as ER-AP-1 was not activated by tamoxifen in human breast cancer cells (26) . Interestingly, Weisz and Rosales (27) previously reported [ 32 P]fos3 binds both the ER and AP-1 transcription factors in a gel mobility shift assay. In contrast, the corresponding plasmid containing the fos3 (Ϫ1222 to Ϫ1997) insert was not E 2 responsive in transient transfection assays in HeLa cells (cotransfected with wild-type ER). Thus, the AP-1 site in the c-fos gene promoter was not responsive to E 2 in HeLa cells or breast cancer cells, and these results further emphasize the importance of both promoter and cellular context for hormone-induced activation (26) .
In summary, the results of this study show that the induction of fos protooncogene expression by E 2 in MCF-7 cells is regulated through interaction of an ER/Sp1 protein complex binding to a GC-rich (Sp1) region in the promoter (Ϫ1168 to Ϫ1161), and this represents the first example of an E 2 -responsive gene regulated by this complex interacting with a GC-rich motif. These data are in contrast to a report by Weisz and Rosales (27) , who identified an imperfect palindromic ERE that was required for E 2 -induced trans-activation in HeLa cells. The results of preliminary studies in this laboratory using HeLa cells were not in conflict with the previous report (27) , and the 5Ј-GGGGCGTGG-3Ј sequence was not required for E 2 responsiveness in HeLa cells (data not shown). Thus, genomic Sp1-binding sites may play an important role in the E 2 responsiveness of some genes and also influence cell-and promoter/gene-specific differences in hormone-induced trans-activation (41) . Current research in this laboratory is focused on studying functional Sp1 sites in other E 2 -responsive genes that play a role in ER-mediated trans-activation in diverse mammalian cell lines.
